These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

62 related items for PubMed ID: 10218130

  • 1. Establishment of an in vivo human myeloid leukemia model in the SCID mouse.
    Arai C, Tsuzaki Y, Arai N, Takeuchi M, Kurimoto M, Nagano Y.
    In Vivo; 1999; 13(1):35-40. PubMed ID: 10218130
    [Abstract] [Full Text] [Related]

  • 2. In vivo therapeutic effects of IFN-gamma on human myelogenous leukemia in a severe combined immunodeficiency mouse model.
    Arai C, Tsuzaki Y, Nagano Y.
    In Vivo; 1999; 13(6):445-51. PubMed ID: 10757035
    [Abstract] [Full Text] [Related]

  • 3. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
    Cesano A, Hoxie JA, Lange B, Nowell PC, Bishop J, Santoli D.
    Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
    [Abstract] [Full Text] [Related]

  • 4. Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice.
    Beran M, Pisa P, Kantarjian H, Porwit A, Bjorkholm M.
    Hematol Pathol; 1994 May; 8(4):135-54. PubMed ID: 7860433
    [Abstract] [Full Text] [Related]

  • 5. JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
    Uesato N, Fukui K, Maruhashi J, Tojo A, Tajima N.
    Exp Hematol; 2006 Oct; 34(10):1385-92. PubMed ID: 16982331
    [Abstract] [Full Text] [Related]

  • 6. The topoisomerase I inhibitor DX-8951f is active in a severe combined immunodeficient mouse model of human acute myelogenous leukemia.
    Vey N, Giles FJ, Kantarjian H, Smith TL, Beran M, Jeha S.
    Clin Cancer Res; 2000 Feb; 6(2):731-6. PubMed ID: 10690560
    [Abstract] [Full Text] [Related]

  • 7. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M, Frankel AE, Alexander RL, Gerhard B, Hogge DE.
    Cancer Res; 2002 Mar 15; 62(6):1730-6. PubMed ID: 11912147
    [Abstract] [Full Text] [Related]

  • 8. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 9. [Establishment and comparison of two intraperitoneally transplanted human ovarian carcinoma models with immune reconstitution in severe combined immunodeficient mice].
    Li Y, Cui H, Chang XH, Feng J, Fu TY, Feng YJ, Wei LH.
    Ai Zheng; 2004 Feb 15; 23(2):160-4. PubMed ID: 14960235
    [Abstract] [Full Text] [Related]

  • 10. [Experimental study of 131I-labeled granulocyte macrophage colony-stimulating factor in SCID mouse-acute myeloid leukemia model].
    Deng YJ, Lou SF, Xu YZ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan 15; 28(1):33-6. PubMed ID: 17649724
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
    Dürig J, Ebeling P, Grabellus F, Sorg UR, Möllmann M, Schütt P, Göthert J, Sellmann L, Seeber S, Flasshove M, Dührsen U, Moritz T.
    Cancer Res; 2007 Sep 15; 67(18):8653-61. PubMed ID: 17875705
    [Abstract] [Full Text] [Related]

  • 13. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
    Liang ZX, Cheng Q, Chen HZ, Xie X, Ye DF.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1465-9. PubMed ID: 15500747
    [Abstract] [Full Text] [Related]

  • 14. [Development of intraperitoneally transplantated human ovarian carcinoma model with immune reconstruction in severe combined immunodeficient mice].
    Zhu H, Ye D, Chen H, Lu W, Xie X.
    Zhonghua Yi Xue Za Zhi; 2002 May 10; 82(9):630-3. PubMed ID: 12133487
    [Abstract] [Full Text] [Related]

  • 15. Engraftment of human T-cell acute lymphoblastic leukemia in immunodeficient NOD/SCID mice which have been preconditioned by injection of human cord blood.
    Dialynas DP, Shao L, Billman GF, Yu J.
    Stem Cells; 2001 May 10; 19(5):443-52. PubMed ID: 11553853
    [Abstract] [Full Text] [Related]

  • 16. [Biodistribution study of 131I-gM-CSF in SCID mice bearing human leukemia].
    Xu YZ, Lou SF, Deng YJ.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Oct 10; 27(10):678-81. PubMed ID: 17343200
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia.
    Zhang M, Zhang Z, Garmestani K, Goldman CK, Ravetch JV, Brechbiel MW, Carrasquillo JA, Waldmann TA.
    Cancer Res; 2004 Aug 15; 64(16):5825-9. PubMed ID: 15313926
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia.
    Cheung AM, Chow HC, Liang R, Leung AY.
    Br J Haematol; 2009 Feb 15; 144(4):484-91. PubMed ID: 19055666
    [Abstract] [Full Text] [Related]

  • 20. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
    Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A.
    Clin Cancer Res; 2002 Apr 15; 8(4):1277-83. PubMed ID: 11948143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.